BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1592 related articles for article (PubMed ID: 17164146)

  • 1. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation.
    Liu C; Xu D; Sjöberg J; Forsell P; Björkholm M; Claesson HE
    Exp Cell Res; 2004 Jul; 297(1):61-7. PubMed ID: 15194425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
    Bott SR; Arya M; Kirby RS; Williamson M
    Prostate Cancer Prostatic Dis; 2005; 8(4):321-6. PubMed ID: 16276353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
    Carvalho JR; Filipe L; Costa VL; Ribeiro FR; Martins AT; Teixeira MR; Jerónimo C; Henrique R
    Apoptosis; 2010 Aug; 15(8):956-65. PubMed ID: 20464497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
    Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
    Tang H; Goldberg E
    J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
    Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
    Kelavkar UP; Parwani AV; Shappell SB; Martin WD
    Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.